Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accreted, cooperating, FD, imposed, imvexxy, IMVEXXYTM, nutritional, Obsolescence, obsolete, paper, perspective, portfolio, pro, progestogen, rata, raw, reclassified, scope, sensitivity, TM, travel, ultimate, unfunded, unmarketable, unopposed, violated, widely
Removed:
absorption, added, administered, advantage, aim, approvability, beta, Bone, bothersome, brought, competing, conjugated, CRL, DBRUP, demonstrating, Division, easier, enabling, enhanced, estrone, formally, frame, initiated, lack, medical, negligible, onset, painful, parabasal, participated, pH, pharmacokinetic, positively, postmenopausal, program, randomized, REJOICE, Reproductive, request, resolution, resolve, show, significance, simple, statistical, superficial, supported, sustained, systemic, tolerated, traditional, type, Urologic, week, weekly
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Softgel Commercial Supply Agreement
- 10.2 Credit and Security Agreement
- 10.3 Fourth Amendment to Lease
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer
- 32.2 Certification of Chief Financial Officer
- Download Excel data file
- View Excel data file
Related press release
Associated TXMD transcripts
TXMD similar filings
Filing view
External links
Exhibit 32.1
SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
In connection with the quarterly report of TherapeuticsMD, Inc. (the "Company") on Form 10-Q for the quarterly period ended June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert G. Finizio, Chief Executive Officer of the Company, certify, to my best knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
July 30, 2018 | /s/ Robert G. Finizio |
Robert G. Finizio | |
Chief Executive Officer | |
(Principal Executive Officer) |
A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.